Cargando…

Energy expenditure during gait in patients with mucopolysaccharidosis

OBJECTIVE: The aim of this study is to evaluate energy expenditure in gait by mucopolysaccharidosis affected patients by means of a simple and adequate to the clinical environment methodology. METHODS: A cross-sectional study was carried out comparing energy expenditure during gait in 19 patients su...

Descripción completa

Detalles Bibliográficos
Autores principales: Matos, Marcos Almeida, Prado, André, Schenkel, Gustavo, Barreto, Rosa, Acosta, Angelina Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Ortopedia e Traumatologia Regional de São Paulo 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861965/
https://www.ncbi.nlm.nih.gov/pubmed/24453654
http://dx.doi.org/10.1590/S1413-78522013000200009
_version_ 1782295701501247488
author Matos, Marcos Almeida
Prado, André
Schenkel, Gustavo
Barreto, Rosa
Acosta, Angelina Xavier
author_facet Matos, Marcos Almeida
Prado, André
Schenkel, Gustavo
Barreto, Rosa
Acosta, Angelina Xavier
author_sort Matos, Marcos Almeida
collection PubMed
description OBJECTIVE: The aim of this study is to evaluate energy expenditure in gait by mucopolysaccharidosis affected patients by means of a simple and adequate to the clinical environment methodology. METHODS: A cross-sectional study was carried out comparing energy expenditure during gait in 19 patients suffering from mucopolysaccharidosis (MPS Group) with 19 asymptomatic control individuals (Control Group). Energy expenditure was measured in calories (cal) using a Polar telemetric watch (model FT7) during a 50 meter walk. Variables such as age, weight, height, body mass index (BMI), initial hart rate, final hart rate, and walking time, were recorded. RESULTS: MPS Group showed a mean energy expenditure during gait of 2.84 cal (±1,01), versus 1.42 cal (±0,51), 100% higher than the Control Group; MPS also presented increased initial hart rate (22% higher), final hart rate (13% higher) and walking time (13% higher). CONCLUSIONS: Energy expenditure during gait in MPS patients was two times higher than control individuals; the methodology used showed to be a promising alternative, also adequate to the standard clinical environment. Level of Evidence III, Cross-sectional Comparative Study.
format Online
Article
Text
id pubmed-3861965
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Sociedade Brasileira de Ortopedia e Traumatologia Regional de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-38619652014-01-22 Energy expenditure during gait in patients with mucopolysaccharidosis Matos, Marcos Almeida Prado, André Schenkel, Gustavo Barreto, Rosa Acosta, Angelina Xavier Acta Ortop Bras Original Article OBJECTIVE: The aim of this study is to evaluate energy expenditure in gait by mucopolysaccharidosis affected patients by means of a simple and adequate to the clinical environment methodology. METHODS: A cross-sectional study was carried out comparing energy expenditure during gait in 19 patients suffering from mucopolysaccharidosis (MPS Group) with 19 asymptomatic control individuals (Control Group). Energy expenditure was measured in calories (cal) using a Polar telemetric watch (model FT7) during a 50 meter walk. Variables such as age, weight, height, body mass index (BMI), initial hart rate, final hart rate, and walking time, were recorded. RESULTS: MPS Group showed a mean energy expenditure during gait of 2.84 cal (±1,01), versus 1.42 cal (±0,51), 100% higher than the Control Group; MPS also presented increased initial hart rate (22% higher), final hart rate (13% higher) and walking time (13% higher). CONCLUSIONS: Energy expenditure during gait in MPS patients was two times higher than control individuals; the methodology used showed to be a promising alternative, also adequate to the standard clinical environment. Level of Evidence III, Cross-sectional Comparative Study. Sociedade Brasileira de Ortopedia e Traumatologia Regional de São Paulo 2013 /pmc/articles/PMC3861965/ /pubmed/24453654 http://dx.doi.org/10.1590/S1413-78522013000200009 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Matos, Marcos Almeida
Prado, André
Schenkel, Gustavo
Barreto, Rosa
Acosta, Angelina Xavier
Energy expenditure during gait in patients with mucopolysaccharidosis
title Energy expenditure during gait in patients with mucopolysaccharidosis
title_full Energy expenditure during gait in patients with mucopolysaccharidosis
title_fullStr Energy expenditure during gait in patients with mucopolysaccharidosis
title_full_unstemmed Energy expenditure during gait in patients with mucopolysaccharidosis
title_short Energy expenditure during gait in patients with mucopolysaccharidosis
title_sort energy expenditure during gait in patients with mucopolysaccharidosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861965/
https://www.ncbi.nlm.nih.gov/pubmed/24453654
http://dx.doi.org/10.1590/S1413-78522013000200009
work_keys_str_mv AT matosmarcosalmeida energyexpenditureduringgaitinpatientswithmucopolysaccharidosis
AT pradoandre energyexpenditureduringgaitinpatientswithmucopolysaccharidosis
AT schenkelgustavo energyexpenditureduringgaitinpatientswithmucopolysaccharidosis
AT barretorosa energyexpenditureduringgaitinpatientswithmucopolysaccharidosis
AT acostaangelinaxavier energyexpenditureduringgaitinpatientswithmucopolysaccharidosis